title: The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.
abstract: Telomerase, a ribonucleoprotein important to neoplastic immortality, is up-regulated in approximately 85% of cancers, including leukemias. In this study, 9cUAB30, a novel retinoic acid, resulted in differentiation of HL60 leukemia cells as indicated by morphologic changes characteristic of granulocytes. It also caused a down-regulation of hTERT gene expression and a decrease in telomerase activity. Telomerase inhibition was followed by loss of proliferative capacity, induction of apoptosis, and partial differentiation. These findings demonstrate the effectiveness of 9cUAB30 at inhibiting telomerase activity by down-regulating hTERT gene expression in human leukemic cells.
authors.affiliation: Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
authors.forename: William K
authors.initials: WK
authors.lastname: Love
authors.forename: J Tyson
authors.initials: JT
authors.lastname: Deangelis
authors.forename: Joel B
authors.initials: JB
authors.lastname: Berletch
authors.forename: Sharla Mo
authors.initials: SM
authors.lastname: Phipps
authors.forename: Lucy G
authors.initials: LG
authors.lastname: Andrews
authors.forename: Wayne J
authors.initials: WJ
authors.lastname: Brouillette
authors.forename: Donald D
authors.initials: DD
authors.lastname: Muccio
authors.forename: Trygve O
authors.initials: TO
authors.lastname: Tollefsbol
references.citation: J Med Chem. 1998 May 7;41(10):1679-87
references.pmid: 9572893
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6662-7
references.pmid: 11371621
references.citation: Science. 1994 Dec 23;266(5193):2011-5
references.pmid: 7605428
references.citation: Br J Cancer. 1999 Jun;80(8):1156-61
references.pmid: 10376966
references.citation: Chin Med J (Engl). 1996 Mar;109(3):179-82
references.pmid: 8758302
references.citation: Nature. 1992 Jan 30;355(6359):441-6
references.pmid: 1310350
references.citation: Int J Oncol. 2007 Mar;30(3):641-50
references.pmid: 17273765
references.citation: Carcinogenesis. 2006 Jun;27(6):1232-9
references.pmid: 16344269
references.citation: Cancer Res. 1983 Jul;43(7):3034-40
references.pmid: 6189589
references.citation: Int J Oncol. 2000 Nov;17(5):971-6
references.pmid: 11029500
references.citation: J Surg Res. 2000 Oct;93(2):206-10
references.pmid: 11027462
references.citation: Cancer Lett. 2003 Nov 10;201(1):17-24
references.pmid: 14580682
references.citation: Diagn Mol Pathol. 2002 Sep;11(3):177-85
references.pmid: 12218458
references.citation: Gene. 2003 Oct 16;316:57-65
references.pmid: 14563552
references.citation: Exp Cell Res. 2002 Jan 15;272(2):185-91
references.pmid: 11777343
references.citation: Med Hypotheses. 2001 Jun;56(6):630-7
references.pmid: 11399111
references.citation: J Med Chem. 1996 Sep 13;39(19):3625-35
references.pmid: 8809153
references.citation: Anal Biochem. 2003 Apr 1;315(1):1-21
references.pmid: 12672407
references.citation: Eur J Cancer. 1997 Apr;33(5):787-91
references.pmid: 9282118
references.citation: Blood. 1996 Mar 1;87(5):1977-84
references.pmid: 8634447
references.citation: J Cell Biochem. 1997 Oct 1;67(1):13-23
references.pmid: 9328835
references.citation: Leukemia. 1998 Dec;12(12):1866-80
references.pmid: 9844917
references.citation: Nutr Rev. 1994 Feb;52(2 Pt 2):S32-44
references.pmid: 8202281
references.citation: Gene. 2001 May 16;269(1-2):1-12
references.pmid: 11376932